Description

BSE permits trading of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025.

Summary

BSE has announced the listing and trading permission for 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were previously kept in abeyance. These shares will be available for trading from September 1, 2025.

Key Points

  • 1000 bonus equity shares of Rs. 1/- each are being listed
  • Shares were previously kept in abeyance
  • ISIN: INE571A01038
  • Distinctive numbers: 1171453 to 1172452
  • Trading commences September 1, 2025

Regulatory Changes

No regulatory changes - this is a standard listing notification for previously issued but held shares.

Compliance Requirements

Trading members are informed and can facilitate trading of these securities from the effective date.

Important Dates

  • Effective Trading Date: September 1, 2025 (Monday)
  • Notice Date: August 29, 2025

Impact Assessment

Minimal market impact expected due to the small number of shares (1000) relative to the company’s total equity base. This is a routine administrative listing of bonus shares that were previously held in abeyance.

Impact Justification

Small bonus share listing with minimal market impact